Prognostic impact of CD163 and CD11c in B cell lymphomas
Diffuse large B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) are aggressive non-Hodgkin lymphomas often diagnosed at advanced stages in elderly patients. Current tools for patient stratification do not sufficiently identify patient groups resistant to treatment. The presence of CD11c+ cells has previously been associated with pro-inflammatory tumour-immune microenvironment (TIME), while CD
